On ECHEMI
Home > Drugs > Levofloxacin hydrochloride ear drops

Levofloxacin hydrochloride ear drops

Function and Efficacy

Pharmacological action Levofloxacin is the levorotatory form of ofloxacin, and its antibacterial activity is about twice that of ofloxacin. Its main mechanism of action is to inhibit the activity of bacterial topoisomerase IV and DNA gyrase (both are type II topoisomerases), hindering the replication of bacterial DNA to achieve antibacterial effect. Levofloxacin has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Escherichia coli, Klebsiella, Serratia, Proteus, Shigella, Salmonella, Citrobacter, Acinetobacter, and Gram-negative bacteria such as Pseudomonas aeruginosa, Haemophilus influenzae, and Neisseria gonorrhoeae. It also has good antibacterial effect on some methicillin-sensitive Staphylococci, Streptococcus pneumoniae, Streptococcus pyogenes, hemolytic Streptococci, and Legionella, Mycoplasma, and Chlamydia, but has poor effect on anaerobic bacteria and enterococci. Toxicological studies Genetic toxicity: The results of the Ames test, CHO/HGPRT mutation test, mouse micronucleus test, rat unscheduled DNA synthesis test (UDS), and mouse sister chromosome exchange test were all negative. The results of the in vitro CHL cell line chromosome aberration test and CHL/IU cell line sister chromosome exchange test were all positive. Carcinogenicity: Rats were given levofloxacin up to 100 mg/kg/day by dietary administration for 2 consecutive years, and no carcinogenicity was observed.

Ingredients

Levofloxacin Hydrochloride

Name Description Content CAS NO. Manufacturer
Levofloxacin hydrochlorideIngredients

It achieves antibacterial effect by inhibiting the activity of bacterial topoisomerase IV and DNA gyrase, hindering the replication of bacterial DNA. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect, and has good antibacterial effect on most Enterobacteriaceae, some Gram-positive bacteria, Legionella, Mycoplasma, Chlamydia, but has poor effect on anaerobic bacteria and enterococci.

More
177325-13-2 18

Appearance

This product is a light yellow-green clear liquid.

Indication

Used to treat otitis externa and otitis media caused by sensitive bacteria.

Usage and Dosage

Ear drops. Adults should use 6-10 drops at a time, 2-3 times a day. After ear drops, bathe the ears for about 10 minutes. Increase or decrease the number of ear drops according to symptoms.

Adverse Reactions

Occasionally there is middle ear pain and itching.

Precautions

Patients who are allergic to this product and fluoroquinolones are contraindicated.

Special Population Medication

Precautions for children: Generally not for infants and young children. Precautions for pregnancy and lactation: Pregnant women should not use it. It can be used with caution only when there is an indication for use and the benefits outweigh the disadvantages. Breastfeeding women should stop breastfeeding when using it. Precautions for the elderly: Not yet clear.

Drug Interactions

Long-term and excessive use, after local absorption, may produce the same drug interactions as systemic medications, such as increasing the blood concentrations of drugs such as cyclosporine and probenecid, and interfering with the metabolism of caffeine.

Storage

seal.

Packaging Specification

0.5%

Validity Period

24 months

Manufacturer

Shen ZHEN WAN HE Pharmaceutical Co., Ltd.

  • Founded in:

    1992-07-28
  • Address:

    Vanward Technology Building, No. 7 Huitong Road, Fenghuang Street, Guangming New District, Shenzhen
  • Tax NO.:

    91440300618806532U
  • Registered Funds:

    113.9981 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.